Navigation Links
Data From Phase II Trial of Prolor Biotech's Long-acting Human Growth Hormone Presented at Endo 2012
Date:6/26/2012

hormone, and they further validate the dosing regimen for the company's planned Phase III trial. 

The study, Once-Weekly, CTP-Modified hGH (MOD-4023) Is Effective in Growth Hormone Deficient Adults: A Phase II Dose and Frequency Finding Study, was discussed in an oral presentation on June 25, 2012 by clinical investigators who oversaw the Phase II trial.  For more information on ENDO 2012, visit www.endo-society.org/endo.

ABOUT PROLOR
PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales.  The CTP technology is applicable to virtually all proteins.  PROLOR is currently developing a long-acting version of human growth hormone, which has successfully completed a Phase II clinical trial.  It also is developing long-acting versions of Factor VIIa and Factor IX for hemophilia and a GLP-1/Glucagon dual receptor agonist peptide for diabetes and obesity, all of which are in preclinical development.  For more information, visit www.prolor-biotech.com.

 Safe Harbor Statement:  This press release contains forward-looking statements, which may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "would", "intends," "estimates," "suggests," "has the potential to" and other words of similar meaning, including statements regarding the results of current clinical studies and preclinical experiments and the effectiveness of PROLOR's long-acting protein programs, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned tha
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Penn researchers study of phase change materials could lead to better computer memory
2. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
3. BioPharm Systems Launches Services to Help Phase I Clinics Implement Oracle Health Sciences LabPas
4. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
5. Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
6. Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
7. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis
8. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
9. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
10. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
11. Xention Reports Positive Phase 1 Data for New Atrial Fibrillation Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... MA (PRWEB) June 20, 2013 Belatrix ... firm , today released news on its latest initiative ... BSIU initiative brings together leading thought leaders, and business ... webcasts and dynamic workshops. The goal of the initiative ... to gain fresh inspiration for their product innovation efforts. ...
(Date:6/20/2013)... June 20, 2013 Confluent is a ... of medical, software, manufacturing, safety, chemical, B2B, retail and ... Charlene Nagy, Confluent’s President and CEO, they had ... engage prospects and client via social media, and direct ... and converted to new clients. “What was missing was ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 For an ... Waterless Bead Baths using metallic beads instead ... electricity, and do not require germicides. Yet, the bead ... because the bath is always ready unlike a water ... create a dry bath, which eliminates the contamination and ...
(Date:6/19/2013)... June 19, 2013  U.S. Secretary of State ... which distinguished Syngenta  scientist Mary-Dell Chilton , ... World Food Prize. The prize is the foremost international ... improving the quality, quantity or availability of food in ... laureates were recognized for "revolutionary biotechnology discoveries that unlocked ...
Breaking Biology Technology:Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation 2Confluent Translations Consolidates Marketing Efforts 2Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2
... SOUTH SAN FRANCISCO, Calif. , April 29 ... new therapeutics discovered using cellular reprogramming and directed differentiation ... awarded a three-year $1.5 million "Basic Biology ... The grant will be used to fund the study ...
... , VIENNA , April 29, 2010 ... and an obnoxious plant called,Chinese Giant Knotweed, actually improve your brain function? ... ... study in the journal, American Journal of,Clinical Nutrition, which concludes that a ...
... ... and pharmacovigilance training provider, will be speaking today at the 2010 ... President of eLearning and Informatics, will present BioSoteria’s experience with Trivantis ... create online pharmacovigilance training courses for the biopharmaceutical industry. ...
Cached Biology Technology:iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming 2iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming 3Your Brain on Resveratrol 2Your Brain on Resveratrol 3Your Brain on Resveratrol 4Your Brain on Resveratrol 5Drug Safety Firm BioSoteria to Present on eLearning Development Experience 2Drug Safety Firm BioSoteria to Present on eLearning Development Experience 3
(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...
(Date:6/18/2013)... are expecting a very large "dead zone" in the ... level in the Chesapeake Bay this year, based on ... University of Michigan, Louisiana State University, and the ... Gulf of Mexico hypoxic "dead" zone will be between ... among the ten largest recorded. That would range from ...
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... eliminate malaria worldwide, new strategies are needed to find ... signs of the disease. The prevalence of asymptomatic or ... percent in populations with malaria and these asymptomatic individuals ... in areas where disease transmission has declined. ...
... latest news and discoveries in medicine, physics, environmental science, ... Annual Meeting of the Biophysical Society (BPS), held Feb. ... Convention Center in San Diego, Calif. With more than ... research scientists in attendance each year, the BPS Annual ...
... of scientists studying the effects of electron-beam irradiation on ... in the February issue of the leading microbiology journal, ... lead investigator. The study quantified the theoretical health-risk ... electron-beam irradiation. "The purpose of this study was ...
Cached Biology News:'Test and Treat' model offers new strategy for eliminating malaria 2Highlights of the Biophysical Society 56th Annual Meeting 2Highlights of the Biophysical Society 56th Annual Meeting 3Highlights of the Biophysical Society 56th Annual Meeting 4Highlights of the Biophysical Society 56th Annual Meeting 5Highlights of the Biophysical Society 56th Annual Meeting 6Highlights of the Biophysical Society 56th Annual Meeting 7Highlights of the Biophysical Society 56th Annual Meeting 8Highlights of the Biophysical Society 56th Annual Meeting 9Highlights of the Biophysical Society 56th Annual Meeting 10Study shows electron-beam irradiation reduces virus-related health risk in lettuce, spinach 2Study shows electron-beam irradiation reduces virus-related health risk in lettuce, spinach 3
... is a high-quality four-place microplate shaker with ... speed is adjustable from 100 to 1350 ... a small orbit ensure effective shaking for ... quick and easy to set for 0 ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... The dotLab System brings together ... diffraction and immobilized capture surfaces. This ... simple technique for the detection of ... of fluorescent labels. , Protein-specific capture ...
... provides a comprehensive experiment based analysis package ... menus yet sophisticated and powerful functionality., Image ... CCD cameras for easy image capture. ... Digital Video Playback Saturation Warning ...
Biology Products: